4
Changes in Ownership
HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-23-042480
EVP, Chief Operating Officer gave up 2,012 shares (to pay taxes)
- EVP, Chief Operating Officer acquired 5,814 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Szekeres David Leslie EVP, Chief Operating Officer | 2023-07-13 | Option exercise | +1,250 | 31,202 | D | ||
| Szekeres David Leslie EVP, Chief Operating Officer | 2023-07-13 | Option exercise | +4,564 | 35,766 | D | ||
| Szekeres David Leslie EVP, Chief Operating Officer | 2023-07-13 | Shares withheld for taxes | −2,012 | $1.31 | $2,636 | 33,754 | D |
| Derivatives | |||||||
| Szekeres David Leslie EVP, Chief Operating Officer | 2023-07-13 | Option exercise · Restricted Stock Units | −1,250 | 6,250 | D | ||
| Szekeres David Leslie EVP, Chief Operating Officer | 2023-07-13 | Option exercise · Restricted Stock Units | −4,564 | 23,372 | D | ||
Loading xslF345X05/doc4.xml…